Amazon’s new healthcare approach mines medical records

Amy Baxter | | Health Exec | Digital Transformation

Amazon is now selling software that “mines” medical records of patients to find ways to improve care and lower costs for providers, according to a report from The Wall Street Journal.

Amazon has several other forays into the healthcare space, including a joint venture with Berkshire Hathaway and JPMorgan Chase to create a new entity that focuses on improving healthcare for employees of the three companies.

The latest move takes aim at a market worth more than $7 billion a year, to store and analyze health information, according to the report. The software reads digitized patient records using deep learning to find specific data points.

Demand for this capability is likely to increase.

See the full story below:

Big Tech Expands Footprint in Health

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

5 ways AI can help make healthcare more affordable for everyone
HIMSS survey report: Beware insider threats to cybersecurity involving AI
Primary care is primed for AI. But is AI aligned with primary care?
Machine learning vs. bodily pain: 5 points of promise and challenge
Generative AI isn’t changing everything for patients and providers—but it’s not leaving much unaffected, either
Antibiotics prescriptions: There’s a large-language model for that

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.